Inventor · disambiguated record
Jan Münch
Also filed as: MUENCH JAN · MUNCH JAN · MÜNCH JAN
7 granted patents·3 pending applications·13 citations·filing 2000–2022
76Inventor score
Files withIPF PHARMACEUTICALS GMBH4FORSSMANN WOLF GEORG1MUENCH JAN1PHARIS BIOTEC GMBH1STAENDKER LUDGER1
Top patents by PatentIndex Score
10 records- 0178US9045563B2CXC chemokine receptor 4 (CXCR4) antagonistic polypeptideFORSSMANN WOLF-GEORG·Filed 2008·Granted Jun 2, 2015·4 cites·9 claims
- 0273US7037896B1Peptide (VIRIP) which inhibits a circulating virus in humans and the use thereofIPF PHARMACEUTICALS GMBH·Filed 2000·Granted May 2, 2006·8 cites·4 claims
- 0361US8652483B2Viral infection enhancing peptideMUENCH JAN·Filed 2011·Granted Feb 18, 2014·1 cites·12 claims
- 0456US7655629B2Peptides and their use for the treatment of HIV infectionsIPF PHARMACEUTICALS GMBH·Filed 2003·Granted Feb 2, 2010·0 cites·7 claims
- 0555US2024190918A1Fibril peptidesUNIV ULM·Filed 2022·Application pending·0 cites
- 0652US10294272B2Peptides with antagonistic activities against natural CXCR4PHARIS BIOTEC GMBH·Filed 2014·Granted May 21, 2019·0 cites·11 claims
- 0748US7741287B2Peptides for the treatment of herpes virus infectionsIPF PHARMACEUTICALS GMBH·Filed 2005·Granted Jun 22, 2010·0 cites·6 claims
- 0844US2021122771A1New molecular tweezers against neurological disorders and viral infectionsUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 0939US2007123465A1Oligomeric peptides and their use for the treatment of hiv infectionsIPF PHARMACEUTICALS GMBH·Filed 2005·Application pending·0 cites
- 1037US8299031B2Human semen enhancer of viral infection peptides (SEVI) and their useSTAENDKER LUDGER·Filed 2007·Granted Oct 30, 2012·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →